Fig. 3From: Adherence to long-term use of renin-angiotensin II-aldosterone system inhibitors in children with chronic kidney diseaseTrend in use of individual medication class among RASI chronic users. a Medication classes for proteinuria, hypertension-related diseases. b Medication classes for anemia, mineral bone disorders, diabetes and hyperlipidemiaBack to article page